FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - BOERSE MUENCHEN 19:25:16 10/05/2024 BST | ||
| 2.42 EUR | -3.59% |
|
| Current month | +2.54% | ||
| 1 month | -60.13% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 2.42 | -3.59% | 0 |
| 09/05/24 | 2.51 | -7.72% | 0 |
| 08/05/24 | 2.72 | -3.89% | 0 |
| 07/05/24 | 2.83 | +2.91% | 0 |
| 06/05/24 | 2.75 | -3.17% | 0 |
Real-time BOERSE MUENCHEN
Last update May 10, 2024 at 07:25 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG20AV |
| ISIN | DE000GG20AV3 |
| Date issued | 22/01/2024 |
| Strike | 152 $ |
| Maturity | Unlimited |
| Parity | 5.61 : 1 |
| Emission price | 8.42 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.58 € |
|---|---|
| Lowest since issue | 2.09 € |
| Spread | 0.15 € |
| Spread % | 6.15% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat
